chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headache, Fever, body aches, burning stomacj, fatigue Narrative:  employee states: around 9pm day of injection started to experience headache, relieved by acetaminophen. awoke at 1am with severe body aches, slight fever (99.5), and a very severe headache, mach was burning but no diarrhea. last through night and next morning. following day very fatigued.slept another day NOTE- she did test positive for COVID in early December with little to no sx (mild aches, nasal congestion, some fatigue)
Information has been received from a registered nurse concerning a 10 month old female with an ear infection in February 2008, and no drug allergies who on 03-JUL-2007, 05-SEP-2007 and 06-NOV-2007 was vaccinated PO with her first, second and third doses of ROTATEQ (lot# 656391/0238U, 657049/0503U, 657518/1192U). Concomitant drug therapy included AUGMENTIN for the ear infection in February 2008. On 10-MAR-2008 the patient experienced vomiting and received a diagnosis of gastroenteritis and was subsequently hospitalized. The nurse was reading the patient's chart and also noted that the patient had intussusception which was "reduced by air." Laboratory diagnostic studies included flat x-ray on 12-MAR-2008. The patient was discharged from the hospital on 14-MAR-2008, but had no other information about the hospitalization. Subsequently the patient recovered. There was no product quality complaint. No other information available. Gastroenteritis and intussusception were also considered to be immediately life-threatening by the physician. Additional information has been requested. 5/27/08-records received for DOS 3/10-3/12/08-admitted with refractory vomiting for 3 days. Admitted for rehydration. NG placement. Transferred to speciality hospital.   7/15/08-records received for DOS 3/12/08-DX: intussusception. Ultrasound revealed intussusception.
Small bowel obstruction with diffuse bowel and pelvic lymphadenopathy 36 hours after injection; Small bowel obstruction with diffuse bowel and pelvic lymphadenopathy 36 hours after injection; This is a spontaneous report from a contactable physician (patient). A 61-years-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EH9899), intramuscularly on 21Dec2020 12:30 to at single dose on left arm for COVID-19 immunization in hospital. Medical history included crohn's disease. No known allergies. Concomitant medications within 2 weeks of vaccination included estradiol, progesterone, colestipol hydrochloride (COLESTID), ustekinumab (STELARA), cyanocobalamin (B12). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced small bowel obstruction with diffuse bowel and pelvic lymphadenopathy 36 hours after injection on 22Dec2020 22:00 with outcome of recovered in Dec2020. The adverse events resulted in emergency room/department or urgent care, hospitalization for 3 days. Therapeutic measures were taken as a result of event included inpatient observation, nothing by mouth (reported as NPO), intravenous fluids. No COVID prior vaccination, COVID test nasal swab was negative on 23Dec2020 post vaccination. It was not reported as serious.; Sender's Comments: There is not a reasonable possibility that reported events small bowel obstruction and lymphadenopathy are related to BNT162B2 vaccine.  The patient had underlying Crohn's disease, which put patient at risk of developing the event. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Flushed face, red nose, shivers, fatigue, muscle aches, sore throat morning after shot for 24 hours.  Got shingles and flu shot simultaneously.  Had 3rd pfizer (booster) one month earlier.  Received series of rabies shots in July.  Slight case of shingles with first covid shot in February.
This spontaneous report was received from a pharmacist via a company representative and refers to a 28-year-old female patient who was the pharmacist's daughter. The patient's pertinent medical history, drug reactions or allergies and concomitant therapy were not reported. On an unknown date, the patient was vaccinated with a dose of unspecified varicella virus vaccine (dose, frequency, route of administration, lot # and expiration date were not reported). On an unknown date, the patient experienced shingles. The outcome of shingles was not reported. The relatedness between unspecified varicella virus vaccine and the shingles was not reported. Additional information has been requested.
Developed cough thick secretions and SOB, O2 Sats 87% within 15-20 minute after injections. Received Epinephrine 1:1000 0.17 SQ x 2 Decadron 4mg IM X 1, Benadryl given be parent. Home on Orapred. MR received revealing well child check where child received DTap, IPV, and MMR. Shortly thereafter he c/o SOB and cough. Pox 87%. Given Epi SQ and Decadron IM. Pox up to 93%. 2nd dose of Epi given SQ. Child observed for several hours, no wheezing, no cough, no sx.  Sent home on Orapred.
24 hours after receiving my Moderna booster, I developed chest pain, fatigue and lethargy. I also had jugular venous distention. This has gotten better however persists.
This case was reported by a pharmacist via call center representative and described the occurrence of ophthalmic herpes zoster in a 79-year-old female patient who received SHINGRIX (batch number 32GR4, expiry date unknown) for prophylaxis. On 18th June 2018, the patient received the 1st dose of SHINGRIX .5 ml. In July 2018, 14 days after receiving SHINGRIX, the patient experienced ophthalmic herpes zoster (serious criteria GSK medically significant), shingles, skin irritation, eye irritation and numbness facial. On an unknown date, the outcome of the ophthalmic herpes zoster, shingles, skin irritation, eye irritation and numbness facial were recovering/resolving. It was unknown if the reporter considered the ophthalmic herpes zoster, shingles, skin irritation, eye irritation and numbness facial to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX in the left deltoid. Two weeks post vaccination, the patient developed Shingles. The patient had skin irritation on arm, face and eye. The left side of her face was numb. The patient mentioned that, her eye doctor noticed shingles in her eye, and her dermatologist also confirmed that, she had Shingles. The pharmacist stated that, the patient improved and was better at the time of reporting. No further details were provided.
This case was reported by a pharmacist via call center representative and described the occurrence of erythema in a elderly female patient who received SHINGRIX. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a month after receiving SHINGRIX, the patient experienced erythema, induration and pain. On an unknown date, the outcome of the erythema, induration and pain were not recovered/not resolved. It was unknown if the reporter considered the erythema, induration and pain to be related to SHINGRIX. Additional details were reported as follows: In 2018, the patient received SHINGRIX 1 and half weeks before the day of reporting. She still had an induration that was red and painful/achy. The mark was approximately 7x8 mm or cm in size (the reporter wrote down meters but this was presumed to be accidental). The reporter asked to let her know (for both possible sizes of the reaction site) how long it might take to resolve. Also, she asked if there should be a greater delay before administering the second dose. The reporter was asked about the best time frame to wait from after resolution of mark to second dose. The reporter asked if a reaction was experienced after the first vaccination, how likely it was to occur with the second dose and if it was typically worse, the same, or reduced in severity. She further asked if a reaction occurred, how bad should the redness, pain, induration be before it is recommended to not administer the second dose. The healthcare provider heard that reactions were more likely with the elderly and would like more details as to why they occur more frequently. This seemed counter to what the provider expected as the immune system was less active as you age and, therefore, most people had lessened responses and reactions to vaccines. The healthcare provider stated that she could be contacted by phone, email or live chat.
This spontaneous report as received from a Registered Nurse refers to unspecified number of patients of unknown age and gender. The patient's medical history was not provided. It was reported that on unknown dates, the patients might have received doses of improperly stored GARDASIL lot number J009243, expiration date 23-APR-2016 (dose and route of administration not reported). The vaccines were exposed to the following conditions: temperature 3049F for 48 hours (the worst case scenario) at least 5 times. No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient received the COVID vaccine (Pfizer dose 1, lot #EW0182, expiration date 05/22/2021) in his left deltoid at 1425. At 1428, as the pt was walking to the observation area, he was observed falling to the ground. The pt?s girlfriend, protected his head from hitting the ground. EMT staff, Lead RN, and Co-Lead RN responded at 1429. The pt?s girlfriend, told the staff that he was passed out for about 10-15 seconds. Upon arrival from staff, the pt was responsive and alert and oriented x4. The pt denied any pain in his head, difficulty breathing or SOB. Pupils were equal and reactive to light and the client was very diaphoretic (sweaty). At 1430, vital signs were BP: 122/58, P: 55, O2: 97%, and RR: 20. The pt denied history of seizures, any other medical history, allergies and takes no medications. The pt stated ?I am afraid of needles but have never fainted after a vaccine or blood draw?. The pt mentioned the last time he ate was breakfast at 0930. At 1435, the pt no longer felt dizzy or lightheaded and walked over to the observation area to sit in the anti-gravity chair. At 1435, the pt finished a granola bar and juice. Vital signs were taken again at 1445, BP: 128/75, P: 85, O2: 98%, and RR: 16. Lead RN and Co-Lead RN educated the pt on signs and symptoms of adverse reactions and when to go to the ED/call MD. Pt was also educated on sitting in the anti-gravity chair for his second dose of Pfizer. Pt left facility at 1447 walking with a steady gait with girlfriend, pt?s mother picked them up.
Extreme fatigue, fever, chills, headache, body aches and pain at injection site. I know they are all listed I just didn?t know if I needed to report them
Patient received vaccines at well check on 6/26/18. Mom noted redness and swelling around the injection sites that had increased until seen for follow up on 6/28/18. At follow up, IM injection site (KINRIX) noted to have area of redness 9 cm in diameter and SQ injection site (PROQUAD) noted to have area of redness 3 cm in diameter; these areas were slightly raised. Sites are painful when more active. Parent instructed by MD to give BENADRYL and MOTRIN q 6-8 h prn and symptoms should gradually improve.
Got vaccine Oct 7. By Oct 8th I was in pain. I went to the clinic at 8AM could not be seen until 10:00AM. I couldn't sit and/or lay down when the doctor was examining. Had EKG done, x-ray found an enlarged heart. Now I don't know if I have an enlarged heart or not. They had to send me to hospital by ambulance about 3:00PM. I got there about 4:15. When this start in the morning I saw that the left side breast was larger than the right. I never told this to the doctor because by the time I got to the hospital, I could not see the inflammation on my breast. Pain started 6:00AM. I was at the hospital at 4:15 almost 10 hours later. I have been trying to get an appointment with my Dr. since I left the hospital on a antib. Today 10/20/09 I got an appointment for Nov. 5 2009 at 11:15 and I can still tell you I'm not 100% my lungs still hurt. I have pain all around kidney & ovaries it feels like the pain outlines them. I don't know if this is a complication of the vaccine but everything start the next day. I feel out of place. I'm not the person that I used to be.
Patient felt dizzy and light headed. 12:00 PM BP 110/60 pulse 76 resp 20 12:20 PM PB 110/70, pulse 76, resp 18. Placed in Trendelenburg position. 12:20 PM, stable, got up on his own and ambulatory.
On 4/15/09 Patient brought by parents. About 12-18 days after vaccines developed hives on both cheeks and few scattered on lower legs.
2/16/03 Thrombocytopenia; admitted to hosptial; treated WIG and steroids. On Omnicef for ear infection for 1 week prior to thrombocytopenia.
10/13/ 21 17:30 resident observed with T-99.5, P-90, R-19, B/P-150/77, 02-96%RA 10/14/21  6:30am resident stated "I don't feel good" with VS: BP 148/66, Temperature 100.8 ,PR 67 , RR , 21 , O2sat93% RA vomiting, headache, muscle and joint pain 10/14/21 10:30am BP: 121/60 mmHg, Temp:97.2 °F, Pulse: 78 bpm, Resp: 20 Breaths/min, O2: 97 %RA
post vaccine patient went into a seizure state lasting no greater than 15/30 seconds. post seizure patient displayed fatigue with sweating as expected. No medical interventions required .
Started vomiting day after vaccine administration. Two days after administration headache, fever, body aches, muscle weakness, diarrhea, and lack of appetite.
A physician reported that a male child "completed the Prevnar series almost a year ago." Subsequently, at 25 months of age, he developed an unspecified pneumococcal infection. No further info was available at the date of this report. Pneumococcal infection is considered medically important. Additional info received on 03/11/2002, from physician. The pt was diagnosed with right upper/ right middle lobe pneumonia and has recovered. The blood isolate will be serotyped and the physician will be sending follow-up information. Follow-up info received on 03/18/2002, from physician. Notification received that the "local hospital lab could not get the S. Pneumoniae to grow," so there will be no isolate to serotype. Info relevant to VAERS form was requested by midical monitor to physician. Follow up info received on 03/21/2002 from physician. A 25 month old male received a 2nd dose of Prevnar vaccine on 04/25/2001. On 02/23/2002, the child developed a febrile illness with pneumonia. A blood culture was positive for strep pneumoniae. A chest x-ray revealed RML and RLL pneumonia with empyema. On 03/05/2002, a surgical incision and drainage was performed. The outcome was "resolving pneumonia." The lot numbers of the Prevnar vaccines that were administered was also provided with follow up.
CHILD RECEIVED THE PFIZER VACCINE AT AGE 15 YRS.  STATES 16 AND OLDER
Tingling in left arm with numbness in left wrist and left hand about 15 minutes post vaccination. No soreness, redness or swelling. no fever. Still has numbness in left wrist and hand. Continues to have "a cough" that she had pre-vaccination. Has began to sneeze and has vomited a couple of times since the day of vaccination.
Redness on upper chest below her neck.  Pt stated her arms felt tingly.  No hard time breathing.  Pt stated she feels anxious and was concerned
Morning after vaccine: Severe throbbing and stabbing pain in right knee, swollen knee, could not bear weight on Right foot.  Difficult time walking due to pain in knee and inability to bear weight. Pain was on both sides of right knee, not knee cap.  Also joint and muscle pain in both legs, wrists, and shoulders, especially at night.  Head - ache. Feeling hot and cold. These symptoms lasted one week.  Treatment - Ice packs / heat pad / Icy hot cream / capsaicin roll on / ibuprofen / elevation.   (I had a previous injury to right knee ligaments / meniscuses 10 years ago and have occasional knee pain. This was much worse. I think my immune system flared up after the vaccine and caused this). After the first week of symptoms, for 3 months off and on, continued knee pain and knee swelling (although less), and continued joint and muscle pain.  (until mid February 2023).  Then these symptoms resolved. Treatment until mid February -  capsaicin roll on / ibuprofen / elevation / swimming.   .
Client wanted pre-exposure Rabies to work with Raccoons. Received first Rabies vaccines on 7/19/16 tolerated shot well. That night when she got home. She had a fever, around 100.3. took some Ibuprofen. Went to bed. Fever in am was up again, she didn't take it, up near 100.2. She took TYLENOL and MOTRIN x3 times that day. (She is an RN who works in UC). Thursday temp was 101 or even higher per client. She took antipyretics. Friday went to UC. They  gave her IV fluids. WBC was 2.3 and her hepatic labs values where weird (her words). She stopped taking any TYLENOL. She said she forgot to tell the HD she had Graves' Disease. She had some N/ and no appetite. She had a HIV, Mono spot and a few other tests. 7/26/16 She called  me and stated all lab tests came back normal. She was feeling better.
Approximately 10 minutes post vaccination, the patient expressed feeling "funny" and that his throat felt tight and he felt he was about to start sweating. His hands appeared red and were warm to touch, no other flushing noted. Blood pressure and pulse elevated. Benadryl 50mg administered PO. After 45 minutes of observation, vital signs returned to normal, patient noted resolution of tight throat feeling, feeling "funny" and redness of hands. D/C'd home with education regarding epipen use and emergency reasons to contact 911.
Tightness in the chest, chest pain, tightness in the throat, hypoxia. Two doses of IM epinephrine, fluids and diphenhydramine given. Patient transported to Emergency Department for work up.
SEVERE UNCONTROLLABLE SHAKING; SEVERE UNCONTROLLABLE CHILLS; A LITTLE FEVER; BAD HEADACHE; This spontaneous report received from a patient concerned a 52 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 202A21A expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021, the subject experienced severe uncontrollable chills. On 09-APR-2021, the subject experienced a little fever. On 09-APR-2021, the subject experienced bad headache. On 09-APR-2021, the subject experienced severe uncontrollable shaking. Laboratory data included: Body temperature (NR: not provided) 100.5 F. Treatment medications included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from severe uncontrollable chills, a little fever, bad headache, and severe uncontrollable shaking on 11-APR-2021. This report was non-serious.
After I got my second booster, it hurt a little bit for 10-15 minutes and the pain went away. Some days later, I had stool problems, constipation, and on and off diarrhea. Taking medications for my heart arrhythmia caused consistent stool problems in addition to another medication in combination. I went to see a chiropractor to help relieve joint pain and still trying to get scheduled to see a doctor about my stool problems.
Fever; Chills; Body ache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Body ache) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, the patient experienced PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Body ache). At the time of the report, PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Body ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.  No treatment information provided.
Lips burning, & swollen, 45 mins post flu shot, Sent to ER , Started  Prednisone
Baby has been in the NICU with prior apnea episodes. Per the baby's care provider "Pt. received  2 month immunizations and had apnea and subsequent desaturations requiring BBO2 and vigorous stimulation.   It is likely true true and unrelated. Pt. had caffeine d/c?d on 12/27 and likely it?s left the system to cause this reaction to be more profound..'   The 2 month vaccines received include Pediarix, ActHiB, Prevnar-13.    There were other possible reasons for the reaction as noted by the NP, however we wanted to report for the purpose of tracking possible adverse drug reactions.
Narrative: Admission Date: Jan 1,2022 Discharge Date: Jan 4,2022 Primary Diagnosis during Admission/Treatment: Acute on chronic hypoxic respiratory failure secondary to COVID Pneumonia 74 y.o male w/ past medical history of COPD, HTN, OSA, CAD s/p 2V CABG (1997) PCI to LAD 2011, HFrEF (LVEF 37% 3/2020), ICD placement in 2011, and atrial flutter presented to the Emergency Dept with SOB. Patient reported he has been experiencing DOE for last few months but recently began using his home O2 chronically instead of PRN. In the two days prior to coming to the D, he reported having to uptitrate his O2 requirement from 3L to 3.5-4 LPM. CXR obtained in ED was of poor quality but showed hazy opacity in left mid to lower lung opacities. He was admitted for acute on chronic hypoxic respiratory failure. Antibiotics held in favor of primary COVID Pneumonia infection. Started Remdesivir and Dexamethasome per COVID-19 protocol. Oxygen titrated during admission to patient's baseline 3-4 LPM. Underwent walk test 1/4/22 and satted at 95% on 4L after ambulating in the room, which he said was at his baseline. Discharged In stable condition. His immunization dates were the following: Date Immunization Series 04/08/2021 COVID-19 (PFIZER), MRNA, LNP-S, PF, 30 MCG/0 2 03/17/2021 COVID-19 (PFIZER), MRNA, LNP-S, PF, 30 MCG/0 1
Erythematous, Measle-Like Rash on face, Behind ears, and trunk, 101' Fever.
Pt. mother reports that the child has swelling, pain, redness, and warmth on the left upper arm where the vaccines were administered.
Symptoms: flu-like with aches, chills, severe shaking, headache, joint pain, no appetite, extreme fatigue that lasted 2.5 days. Had to remain in bed. Took ibuprofen for pain. Unable to work or leave home for 3 days until recovered
This spontaneous report as received from a registered nurse refers to a patient of unknown demography. Patient's concurrent conditions and relevant medical history was not reported. On 08-JAN-2015, the patient was vaccinated with improperly stored PROQUAD (Merck) (dose, frequency and route unspecified) (lot number: K011314 with expiry date of 14-FEB-2106). Concomitant medications were not reported. The reporter stated that, between 07-JAN-2015 through 19-FEB-2015, the varicella virus vaccine live (Merck) was exposed to 34.4 Fahrenheit temperature which was outside the recommended condition. No adverse effects were reported. The outcome of the events was unknown. The causality of the events with varicella virus vaccine live (Merck) was not reported. Product quality issue was not involved. This is one of the several reports from the same reporter. Additional information has been requested.